Literature DB >> 27933406

Differential Roles for the Coagulation Factors XI and XII in Regulating the Physical Biology of Fibrin.

Joanna L Sylman1, Uranbileg Daalkhaijav2, Ying Zhang3, Elliot M Gray3, Parsa A Farhang3, Tiffany T Chu3, Jevgenia Zilberman-Rudenko3, Cristina Puy3, Erik I Tucker3,4, Stephanie A Smith5, James H Morrissey5, Travis W Walker2, Xiaolin L Nan3, András Gruber3,4, Owen J T McCarty3.   

Abstract

In the contact activation pathway of the coagulation, zymogen factor XII (FXII) is converted to FXIIa, which triggers activation of FXI leading to the activation of FIX and subsequent thrombin generation and fibrin formation. Feedback activation of FXI by thrombin has been shown to promote thrombin generation in a FXII-independent manner and FXIIa can bypass FXI to directly activate FX and prothrombin in the presence of highly negatively charged molecules, such as long-chain polyphosphates (LC polyP). We sought to determine whether activation of FXII or FXI differentially regulate the physical biology of fibrin formation. Fibrin formation was initiated with tissue factor, ellagic acid (EA), or LC polyP in the presence of inhibitors of FXI and FXII. Our data demonstrated that inhibition of FXI decreased the rate of fibrin formation and fiber network density, and increased the fibrin network strength and rate of fibrinolysis when gelation was initiated via the contact activation pathway with EA. FXII inhibition decreased the fibrin formation and fibrin density, and increased the fibrinolysis rate only when fibrin formation was initiated via the contact activation pathway with LC polyP. Overall, we demonstrate that inhibition of FXI and FXII distinctly alter the biophysical properties of fibrin.

Entities:  

Keywords:  Coagulation; FXI-deficiency; FXII-deficiency; Fibrin; Stability; Structure

Mesh:

Substances:

Year:  2016        PMID: 27933406      PMCID: PMC5398924          DOI: 10.1007/s10439-016-1771-7

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  36 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood.

Authors:  C Carrieri; R Galasso; F Semeraro; C T Ammollo; N Semeraro; M Colucci
Journal:  J Thromb Haemost       Date:  2011-01       Impact factor: 5.824

3.  Polyphosphate accelerates factor V activation by factor XIa.

Authors:  Sharon H Choi; Stephanie A Smith; James H Morrissey
Journal:  Thromb Haemost       Date:  2014-10-23       Impact factor: 5.249

4.  Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.

Authors:  P A Von dem Borne; L Bajzar; J C Meijers; M E Nesheim; B N Bouma
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

5.  Polyphosphate exerts differential effects on blood clotting, depending on polymer size.

Authors:  Stephanie A Smith; Sharon H Choi; Rebecca Davis-Harrison; Jillian Huyck; John Boettcher; Chad M Rienstra; Chad M Reinstra; James H Morrissey
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

6.  Platelet phosphatidylserine exposure and procoagulant activity in clotting whole blood--different effects of collagen, TRAP and calcium ionophore A23187.

Authors:  Sofia Ramström; Mats Rånby; Tomas L Lindahl
Journal:  Thromb Haemost       Date:  2003-01       Impact factor: 5.249

7.  Thrombin generation and fibrin formation under flow on biomimetic tissue factor-rich surfaces.

Authors:  A A Onasoga-Jarvis; T J Puls; S K O'Brien; L Kuang; H J Liang; K B Neeves
Journal:  J Thromb Haemost       Date:  2014       Impact factor: 5.824

8.  Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.

Authors:  Marijke J E Kuijpers; Imke C A Munnix; Judith M E M Cosemans; Bart Van Vlijmen; Chris P M Reutelingsperger; Mirjam Oude Egbrink; Johan W M Heemskerk
Journal:  Microcirculation       Date:  2008-05       Impact factor: 2.628

9.  Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk.

Authors:  Alisa S Wolberg; Dougald M Monroe; Harold R Roberts; Maureane Hoffman
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

10.  Discordant fibrin formation in hemophilia.

Authors:  K E Brummel-Ziedins; R F Branda; S Butenas; K G Mann
Journal:  J Thromb Haemost       Date:  2009-01-28       Impact factor: 5.824

View more
  1 in total

1.  The Applicability of Current Turbidimetric Approaches for Analyzing Fibrin Fibers and Other Filamentous Networks.

Authors:  Heather A Belcher; Karen Litwa; Martin Guthold; Nathan E Hudson
Journal:  Biomolecules       Date:  2022-06-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.